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1. SUMMARY 
Baulamycin A and B are a new structural class of 
antibiotics. They come from marine microbial-derived natural 
product extracts collected in Costa Rica, Panama and Papua 
New Guinea.  
From the two types of Baulamycin, Baulamycin A is the one that we are going to synthesize 
because it is able to inhibit microorganisms resistant to Staphylococcus aureus (MRSA), the main 
cause of serious hospital infections. Furthermore, it has been found that Baulamycin is also able 
to inhibit the dangerous and deadly bacterium Anthrax, a bio-terrorist potential agent that is cured 
with extreme difficulty by common antibiotics. 
Unfortunately, Baulamycin A was isolated in a very small quantity and its potential antibiotic 
capacity has not been studied nor has done activity studies. Its structure has been proposed only 
by the analysis of its spectroscopy data. However, the main problem to synthesize this molecule is 
that it owns 7 stereocenters. In order to confirm the structure and test its effectiveness in a 
comprehensive manner as possible drug, the total synthesis is essential. 
My research team in Bologna embarked on the total synthesis of this antibiotic and they have 
identified two possible precursors for the total synthesis. Synthon B can be prepared through the 
execution of three consecutive organocatalytic reactions developed in our laboratories.	 
 
Figure 1: Baulamycin structure and precursors 
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My research in this project is to scale up the reactions to synthon B, try to synthesize 
synthon A and control the relative configuration of the newly formed stereogenic centers. 
Also, we will try to increase the yield obtained in each step in order to get more product. 
However, very recently a research group of the Department of Organic Chemistry of the 
Indian Association for the Cultivation of Science of Jadavpur in Kolkata (India) have 
published in the Journal of Organic Chemistry an article on the Total Synthesis of Reported 
Structure of Baulamycin A and its Congeners. This paper disclosed that the reported 
structure of Baulamycin A needs to be revised, as the spectroscopic data described for the 
synthetic compound are not identical with the real Baulamycin A. 
 
Keywords: Baulamycin A, total synthesis, stereocenters, synthon. 
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2. RESUM 
La Baulamicina A i B pertanyen a una nova classe 
estructural d’antibiòtics. Es vàrem aïllar en extractes marins 
microbians de Costa Rica, Panamà i Papua Nova Guinea. 
Tot i que hi ha dues Baulamicines, la que pretenem sintetitzar és la Baulamicina A, ja que 
és capaç d’eliminar els microorganismes resistents a l’Staphylococcus aureus (MRSA) de 
manera efectiva, bacteris són la primer causa d’infeccions hospitalàries. A més a més, s’ha 
trobat que la Baulamicina pot eliminar l’àntrax, malaltia produïda per un bacteri perillós i mortal, 
que avui en dia és molt difícil de curar amb els antibiòtics que tenim. 
Malauradament, la Baulamicina A va ser aïllada en petites quantitats i el seu potencial com 
a antibiòtic encara no s’ha pogut avaluar amb precisió ni se’n ha obtingut en prou quantitats per 
fer estudis sobre la seva activitat. Ara per ara, només s’ha pogut arribar a proposar la seva 
estructura mitjançant l’anàlisi de les seves dades espectroscòpiques. Per tal de poder confirmar 
la seva estructura i provar-ne l’eficàcia per ser utilitzat com un nou medicament és essencial 
realitzar la seva síntesi total. Ara bé, la síntesi és complicada degut als 7 estereocentres que té 
la seva possible estructura. 
El meu grup de recerca de la Universitat de Bologna està desenvolupant un projecte per 
sintetitzar-la via els dos precursors indicats a la Figura 1. El sintó B pot ser preparat mitjançant 
tres reaccions organocatalítiques consecutives.  
Figura 2: Estructura de la Baulamicina A i els precursors 
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L’objectiu del meu projecte en aquesta línia d’investigació és intentar augmentar l’escala 
de les reaccions assajades fins ara i intentar controlar la configuració relativa dels nous 
centres estereogènics formats. També procurarem augmentar el rendiment obtingut a cada 
pas per tal de poder obtenir més producte final. 
Molt recentment un grup de recerca del Departament de Química Orgànica de la Indian 
Association for the Cultivation of Science de Jadavpur a Kolkata (India) ha publicat al Journal 
of Organic Chemistry un article anomenat Total Synthesis of Reported Structure of 
Baulamycin A and its Congeners. Aquest article demostra que cal revisar l’estructura de la 
Baulamicina A ja que les dades espectroscòpiques descrites pel compost sintetitzat no 
coincideix del tot amb les de la Baulamicina A descrita en el seu aïllament. 
Paraules clau: Baulamicina A, síntesi total, sintó, estereocentres. 
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3. INTRODUCTION 
Nowadays multidrug-resistant pathogens are a serious threat to human health because of 
its ability to develop resistance to antibiotics, this is endangering the management of a multitude 
of serious infections. 
Siderophores are high-affinity iron chelators produced by microorganisms and frequently 
contribute to the virulence of human pathogens. The inhibition of the biosynthesis of 
siderophores is believed to be a potential approach to fight against pathogens. This 
siderophores have developed immunity against antibiotics and this is the reason why the 
discovery of new chemical inhibitors of siderophore biosynthesis is crucial for the development 
of anti-infective agents. 
In order to identify a new structural class of antibiotics, we have selected a marine microbial- 
derived natural product extract which is Baulamycin A because it is an underexplored source of 
novel chemical structures.  
3.1. BACTERIA 
Bacteria are the most numerous and adaptable living organism that inhabit on Earth. They 
take part in the 60% of the Earth biomass and are microscopic single-celled organisms. Their 
dimensions can vary from 0,2 µm to 30 µm and can assume different forms.  
For this class of microorganisms, we can classify them in different shape and appearance. 
The three basic shape of bacteria are spherical, rod shaped and spiral. Not all bacteria are 
capable of causing disease, but each morphology based group has at least some disease-
causing representatives. From its morphology, they can be distinguished as Coccus, Bacillus, 
Vibrio, Spirillum and Spirochete.   
Since bacterial organisms are so minute, it is impossible to view the organisms without a 
compound microscope, so in order to visualize the cellular components and to differentiate 
bacteria from other microbial agents, staining techniques to categorize different bacteria are 
used by scientist.  
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Gram staining is a special method that involves dying the outer covering of the bacterial cell 
wall that prevents it from physical and environmental trauma. This method was named thus 
for Hans Christian Gram, who developed the technique in 1884. Based on gram staining, 
bacteria are widely classified as gram positive, which are the bacteria with the cell wall, and 
the gram negative, which are the bacteria without cell-wall. Cultures of several bacterial 
pathogens containing Baulamycins A and B revealed that these natural products can inhibit 
the growth of both Gram-positive and Gram-negative bacteria. 
3.2. ANTIBIOTICS 
The human being is considered a natural habitat for bacteria, whom will be colonized and 
used for their own benefits in order to guarantee their survival. This is the reason why until the 
discovery of the first antibiotic, many diseases often caused death. Modern research began 
when accidentally penicillin was discovered by Alexander Fleming in 1928. After so, it began a 
period of discoveries and isolation of antibiotics from natural sources, bio-fermentation, and 
chemical synthesis. 
Antibiotics are typically used to treat bacterial infections. However, in recent years, the 
improper or unnecessary use of antibiotics has promoted the expansion of several strains of 
antibiotic-resistant bacteria.  
One of the most notorious antibiotic resistant bacterial strains is methicillin-resistant 
Staphylococcus aureus (MRSA), which resists methicillin and other antibiotics through skin 
contact. MRSA infections occurs in health care where it can lead to pneumonia or 
bloodstream infections.  An important facet of combating antibiotic resistance is to be careful 
about their use.  
Although it is obvious that antibiotics have evolved effectiveness during these years, natural 
selection pressure is imposed thus forcing the growth of the phenomenon of resistance. This 
is the reason why now the medication effectiveness is decreasing and the infection persists 
and increases the risks of contagious and death. A method by which it was possible to 
discover and develop new antibacterial therapies was the semi-synthesis or chemical 
synthesis from natural substances with the aim of improving their effectiveness. But, due to 
the marked antibacterial resistance, this approach is becoming increasingly difficult.  
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3.3. INHIBITION OF THE SIDEROPHORE 
Siderophores are small molecules that exhibit high binding affinity to iron. These are 
secreted by bacteria in order to acquire iron from their surroundings.  
For over 60 yeas, investigations into the bioinorganic chemistry of these molecules, 
including fundamental coordination chemistry studies, have provided insight into the crucial role 
that siderophores play in bacterial iron homeostasis. 
An important aspect in the research and development of new antibiotics, is the study of new 
metabolic pathways that can be used to inhibit the development of pathogenic bacteria. Among 
them, a system that is producing discrete results is what interferes with the iron absorption 
systems by the pathogens agents. Most living organisms, in fact, need iron as an essential 
element for a wide range of metabolic pathways and biosynthetic cells.  
The importance of understanding the fundamental chemistry underlying bacterial life has 
been highlighted evermore in recent years because of the emergence of antibiotic-resistant 
bacteria and the need to prevent the global rise of these superbugs.  
The acquisition of iron is very difficult for many microorganisms, including many important 
human and animal pathogens. Increasing reports of siderophores functioning in capacities other 
than iron transport have appeared recently, but reports of ‘non-classical’ siderophore functions 
have long paralleled those of iron transport. One particular non-classical function of these iron 
chelators is called antibiotic activity.  
An example of siderophore is Enterobaction, which is found mainly in gram-negative 
bacteria such as Escherichia Coli and Salmonella. Typhimurium and Ferrocrom complex consist 
of a cyclic hexapeptide produced by mushrooms of Aspergillus, Ustilago and Penicillium kind. In 
pathogenic organisms are also frequently employed directly to find iron from the body host. In 
this case, the siderophores of the pathogenic bacteria can directly extract the iron protein in 
order to contribute to its proliferation in the vertebrates.  
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The research group of Professor Sherman has managed to isolate directly from the Marine 
organisms Streptomyces Tempisquenis harvested in Playa Grande in Costa Rica the 
Baulamycin A. This molecule has shown very promising effects on the inhibition of 
siderophores like, for example, in the Staphyloferrin B of Staphylococcus aureus, which has 
been attributed to more than 20.000 deaths in one year in the United States, and also Bacillus 
Anthacis Petrolaction the agent that causes Anthrax. 
In particular, Baulamycin A is able to interfere in the first step of the biosynthesis of the 
siderophore, that is the condensation of the citric acid with both spermidine, which is a 
polyamine compound found in ribosomes and living tissues and 2,3-amino propionic acid, with 
the use of AsbA enzymes and SbnE. Even so, the precise inhibition mechanism is still under 
investigation by Sherman’s research team. 
3.4. RETROSYNTHESIS OF THE BAULAMYCIN	
Unfortunately, the extraction of Baulamycin from the marine microorganisms requires large 
amounts of biological material to get a few milligrams of compound after a long process of 
purification.  
In the light of the promising results of biological activity, the research group of Professor 
Cozzi has decided to undertake the total synthesis of this molecule, both to confirm the 
stereochemistry and to undertake a deep study of its inhibition capacity on bacteria resistant 
to antibiotics.  
Such studies are possible thanks to the collaboration with the research group of Professor 
Vittorio Sambri and Doctor Antonella Marangoni who work in the Policlinic San d’Orsola of 
Bologna. The Baulamycin retrosynthesis was designed by the research group and it is briefly 
illustrated below in Scheme 1. The first disconnection of the Baulamycin leads to the synthon 
A (2) and B (3). 
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Scheme 1: Baulamycin Retrosynthesis with synthons 2 and 3 
 
The synthesis of the synthon A (2) has already been studied in detail by the research group 
whereas the synthesis of the synthon B (3) is not since it is much more demanding, due to the 
presence of three stereogenic centers bearing a methyl substituent in relative anti-configuration.  
In scheme 2 we can see that the enantioselective synthesis of such a fragment requires the 
construction of a stereogenic center at a time.   
My contribution to the research group of Dr. Cozzi was synthesizing synthon B up to the first 
methylation (intermediate 8). The same methodology can be used for the next two methylations 
keeping the stereoselectivity by following the homologation process on which the α-methylation 
procedure can be repeated twice in an iterative manner. These reactions have not been 
experimentally tested but there is an approximated idea of how it can be proceed.  
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 Scheme 2: Retrosynthesis of Synthon B 
 
 
In scheme 3, it has been summarized the synthetic approach to obtain synthon B (3) 
through an organocatalytic reaction developed by Professor Cozzi research team. This 
approach allows to carry out an enantioselective α-methylation of aldehydes thanks to the 
alkylation with the 1,3-benzodithiolylium tetrafluoroborate (11) via enamine catalysis.  
 
Scheme 3: Organocatalytic synthesis 
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On the other hand, the aim of the synthesis of synthon A is to find a protecting group for the 
hydroxyls of the aromatic ring. In a previous study, benzyl protecting group was tried but finally 
that approach did not succeed due to the low yield of the reaction. This is the reason why we 
protected the hydroxyl groups with tert-butyldimethylsilyl ether in the aldehyde (25) (see 
Scheme 4). The starting material is commercially available and, with a matter of 4 steps, we can 
get to the aldehyde (25) which will be the precursor of methyl ketone (20). 
 
Scheme 4: Retrosynthesis of Synthon B 
 
3.5. NEW DISCOVERIES 
In February 2017, a research group in Kolkata (India) had published in the Journal of 
Organic Chemistry an article on the Total Synthesis of Reported Structure of Baulamycin A and 
its Congeners. The problem was that the spectroscopic data described for the synthetic 
compound were not identical regarding its natural structure.  
This article guided our research group to think that maybe the real structure of the 
Baulamycin A that we have supposed, was not completely right. We contacted an NMR 
technician that helped us calculate the exact spectroscopic data and show us the real 
stereocenters of the molecule.  
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4. OBJECTIVES 
The main objective of this project is the synthesis of Baulamycin A. The synthetic approach 
can be divided into minor objectives, as shown below: 
 
• Synthesis of an advanced intermediate of synthon A (2). 
• Synthesis of an advanced intermediate of synthon B (3). 
• Focus on the synthesis of the key step to deal with a stereoselective reaction 
using an organocatalytic method in order to obtain the aldehyde (12) on a gram 
scale and proceed towards the total synthesis of synthon B (3). 
• Scaling up each reaction in order to get more quantity of each advanced 
intermediate.  
• Study the spectroscopic characterization of the synthesized products. 
 
Scheme 5: Initial reactant, important intermediate compound and final product 
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5. TOWARDS THE TOTAL SYNTHESIS OF 
BAULAMYCIN A. SYNTHON A 
Scheme 6: Retrosynthetic analysis of Baulamycin A. Synthon A 
 
The proposed retrosynthetic analysis in order to obtain synthon A of the Baulamycin A is 
represented in Scheme 6. These reactions were previously studied in my research group. 
Firstly, a Fischer esterification occurs in order to transform the carboxylic acid (24) into the 
methyl ester (25).  Afterwards, the protection of the hydroxyl groups of the ester (25) was 
performed resulting in the methyl ester (26) which will be reduced to the benzyl alcohol (27) and 
eventually oxidized to the aldehyde (28). In my project, I will synthesize the aldehyde (28), 
which will be our precursor of synthon A (2) and I will try to repeat all the steps proposed from 
my research group and optimize the described reactions. 
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5.1.  FISCHER ESTERIFICATION 
Fischer Esterification is an organic reaction used to convert a carboxylic acid (24) and an 
alcohol into a methyl ester (25) using an acid catalyst. As an alcohol, we used MeOH and as 
an acid catalyst sulphuric acid. This reaction consists in a nucleophilic acyl substitution based 
on the electrophilicity of the carbonyl carbon and the nucleophilicity of an alcohol. The 
reaction was performed at a large scale of 5 grams, giving a quantitative yield as a result.  
Scheme 7: Fischer esterification 
 
The mechanism begins with a protonation of the carbonyl group of the carboxylic acid, 
which is the attacked by the alcohol.  Proton transfer and the subsequent release of water 
result in an oxonium ion intermediate. A final deprotonation step provides the ester product. 
Scheme 8: Mechanism of the Fischer esterification  
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5.2.  PROTECTION OF THE ALCOHOL		
Scheme 9: Protection of the alcohol 
A protecting group was introduced into the methyl 3,5-dihydroxybenzoate (25) in order to 
obtain chemoselectivity in the subsequent chemical reaction. The protection of the alcohol is 
strictly necessary because in the next step, a reduction of an ester is performed in presence of 
an alcohol and, therefore, the attack of the hydride to the alcohol must be prevented. The 
reaction was performed using 3.02 g (17.92 mmol) giving a quantitative yield of (26).  
Scheme 10: Mechanism of the protection of the hydroxyl groups 
 
In our case we chose TBSCl because later on it will be easier to eliminate the protecting 
group using TBAF and also because the use of metals will not be necessary.  
 
5.3.  REDUCTION OF THE ESTER  
Once the hydroxyl groups were protected, we made the reduction of the methyl ester using 
LiAlH4 in THF at 0 ºC for 20 hours, obtaining (3,5-bis ((tert-butyl-dimethylsilyl)oxy)phenyl)-
methanol (27) in a 44% yield. The ester was first converted to aldehyde which will be right after 
reduced to primary alcohol. 
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Scheme 11: Reduction of the ester 
The nucleophilic proton from the hydride reagent assembles with the polar electrophilic 
carbon from the carbonyl group of the ester and creates a tetrahedral intermediate. This 
intermediate collapses and the ethoxyde is expelled as a leaving group giving an aldehyde as 
an intermediate. Later on the reduction of the aldehyde occurs and the nucleophilic H from the 
hydride complex adds to the electrophilic carbon from the carbonyl group of the aldehyde. 
Then it occurs the same procedure as mentioned before and finally we obtain the intermediate 
metal alkoxide complex as shown in scheme 12. 
Reactions run with aluminium based reagents like LiAlH4 form aluminium hydroxide upon 
aqueous quenching, which can create emulsions. In order to quench these and get rid of the 
aluminium salts we use the Fieser method which consists on adding water, 15% aqueous 
sodium hydroxide and anhydrous magnesium sulfate then filter over Celite. The protonation of 
the alkoxide oxygen creates the primary alcohol product from the intermediate complex.	 
Scheme 12: Mechanism of the reduction of the ester 
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5.4.  OXIDATION OF THE ALCOHOL		
Scheme 13: Oxidation of the alcohol 
 
In order to oxidize the alcohol group to the aldehyde we used manganese dioxide which is a 
mild reagent and very selective in benzylic alcohols.  
This reaction was carried out in two different scales, a smaller scale and a bigger scale. The 
oxidation reaction took place inside an open air balloon for 48 hours. Checking the reaction by 
TLC we could not see any spot. Consequently, we increased the equivalence of MnO2 from four 
to six in order to promote the reaction. 
The product was purified by performing a column chromatography obtaining 0.036 g (0.09 
mmol) in the reaction carried out in the smaller scale and 1 g (0.271 mmol) in the bigger scale. 
Neither of the two reactions were as successful as expected. In the smaller scale there was 
no product and in the large scale we achieved 20% yield.  The fact that the reaction did not work 
better could be that the quantity of equivalents of MnO2 were not enough so the MnO2 could not 
be activated or the quality of the reactant was not good.  
We could not remake the reaction again under other conditions. Luckily, we succeeded in 
our attempt to synthesize in higher amounts of the alcohol (27), which will be my precursor for 
synthon A (2). 
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6. TOWARDS THE TOTAL SYNTHESIS OF 
BAULAMYCIN A. SYNTHON B 
Scheme 14: Retrosynthetic analysis of baulamycin A. Synthon B 
The proposed retrosynthetic analysis to obtain Baulamycin A is represented in Scheme 
14.  
It was planned to use the primary alcohol (15) as a starting material, after its oxidation to 
the aldehyde (10) using TEMPO. The key step of the sequence involves the organocatalysis 
with (R)-MacMillan catalyst that was also synthesized. The configuration of the new 
stereocenter was completely controlled due to the imidazolidinone, which provided the 
single enantiomer (12). 
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After the catalytic reaction, removal of the imidazolidinone was possible using Raney Nickel 
giving the chiral alcohol (16), which then it should be oxidised to give the aldehyde (9). In order to 
add more carbon atoms to the chain the homologation process should be taken place with a 
Wittig reaction to afford the unsaturated ester (17) and after the reduction of ester (18). The final 
reaction will be the reduction of the ester into the alcohol (8). 
 
6.1.  OXIDATION OF THE ALCOHOL (14) USING TEMPO 
The first step of the synthesis is the oxidation of the alcohol into the aldehyde by using 
the catalyst TEMPO as shown in scheme 15.  
Scheme 15: Oxidation of the alcohol using TEMPO 
 
TEMPO is a stable free radical and its stability is attributed to the resonance provided by non-
binding electrons on the nitrogen atom. In addition, the four methyl substituents adjacent to the 
nitrogen atom group give a good steric protection preventing the dimerization. TEMPO is 
particularly used in the oxidation of primary and secondary alcohols to their respective aldehydes. 
The addition of KBr produces a substantial acceleration of the oxidation rate because of the 
generation of HOBr. This reagent is formed from HOCl and KBr, and it is apparently a better 
oxidant for the regeneration of oxoammonium salts than HOCl.  
The reaction is much quicker at pH 8.6, therefore, a buffer solution of NaHCO3 was added. 
However, at a very basic pH the concentration of HOBr, which is the oxidant regenerating the 
oxoammonium salt, becomes very low in comparison with the concentration of the hypobromide 
anion (BrO-). 
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The alcohol (14) is oxidized by sodium hypoclorite, stoichiometric oxidizer which 
generated nitrosonium cation, the actual oxidizing agent of the beginning. During the 
oxidation of the alcohol, the cation is reduced to hydroxylamine which then is oxidized and 
returned to nitrosonium ion, completing the catalytic cycle represented in scheme 16. 
Hypochlorite is used as primary oxidant together with bromide as a co-catalyst. 
Tetrabutyl ammonium bromide is used as a phase transfer catalyst to carry hypoclorite 
through the organic phase and make the reaction to take place.  
 
 
Scheme 16: Catalytic cycle of TEMPO 
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6.2.  ORGANOCATALYSIS USING (R)-MACMILLAN IMIDAZOLIDINONE 
Scheme 17: Reaction with the aldehyde 10 and the carbocation 11, with the (R)-MacMillan catalyst 23 
Organocatalysts which display secondary amine functionality can be described as 
performing enamine catalysis by forming catalytic quantities of an active enamine nucleophile. 
This mechanism is typical for covalent organocatalysis. Covalent binding of substrate normally 
requires high catalyst loading, typically 20 mol%.  
Imidazolidinone compounds, which are also called MacMillan organocatalysts, are suitable 
catalysts for many asymmetric reactions such as Diels-Alder reactions.  
The enantioselective alkylation was the key reaction of synthon B, the aldehyde (10) reacted 
with 1,3-benzodithiolylium tetrafluoroborate (11) and with (R)-MacMillan catalyst to obtain 
compound (12), which was reduced with NaBH4 in CH3OH at room temperature for 2 hours.  
We repeated this experiment 16 times in order to get enough product to keep on with the 
synthesis. Each time we used 222 mg of starting aldehyde and the obtained yields were 
comprised between 52% and 68%. The total product (15) weight was 2.383 g and the average 
enantiomeric excess was 95%, this enantiomeric excess was done by HPLC and the conditions 
are shown in section 7.1.  
In scheme 18 below, it is illustrated the mechanism of organocatalysis via enamine 
employing the catalyst (R)-MacMillan and the 1,3-benzodithiolylium tetrafluoroborate (11) as 
carbocation. Benzodithiolylium (11) is commercially available and it can be handled without any 
problem or particular precaution. 
The (R)-MacMillan imidazolidinone catalyst was present in catalytic quantities (20 mol%) 
and it was chosen because the yield obtained was the highest achieved so far and it provided a 
good enantioselectivity. Moreover, as the catalyst is a secondary amine, it was able to react with 
the aldehyde by releasing water and forming the corresponding enamine as shown in the below 
scheme 18. 
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Scheme 18: Catalytic cycle of (R)-MacMillan 
 
6.2.1. SYNTHESIS OF THE (R)-MACMILLAN CATALYST 
The MacMillan organocatalyst was derived from the biomolecule phenylalanine in two 
chemical steps. The first one consisted in an amidation with methylamine followed by a 
condensation reaction with acetone that kept the chirality unchanged.   
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6.2.1.1. FROM THE ACID 19 TO THE METHYL ESTER 20 
The first step in the synthesis of the (R)-MacMillan catalyst, thionyl chloride converts 
carboxylic acids into acid chlorides and then the transformation into an ester occurs. D-
phenylalanine (19) is introduced in a solution of MeOH and SOCl2 is added dropwise. This 
reaction was worked under 0ºC and we obtained (20) with a 76% yield (1.985 g). 
Scheme 19: Catalytic cycle of TEMPO 
6.2.1.2.  AMIDATION WITH METHYLAMINE 
This is the second step for the formation of the oxazolidinone catalyst. In this reaction we 
worked with a methylamine solution in absolute ethanol. The reaction type is a nucleophilic acyl 
substitution to prepare an amide in which we obtained the desired N-methyl amide (21) in a 
quantitative yield. 
Scheme 20: Catalytic cycle of TEMPO 
6.2.1.3. CONDENSATION REACTION WITH ACETONE 
The last step of this synthesis consisted in the condensation of the acetone with the amide 
(21) using p-toluenesulfonic acid (PTSA) as catalyst and anhydrous MeOH as solvent. This 
reaction produced the imine that reacted with HCl in Et2O 1.0 M giving room to the precipitated 
(R)-MacMillan imidazolidinone catalyst (1.572 g, 55%).  
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Scheme 21: Formation of the oxazolidinone catalyst 
6.3.  REDUCTION WITH RANEY NICKEL 
Subsequently, a reduction is made in order to preserve the integrity of the stereogenic 
center of alcohol (13) using the Raney nickel reagent. This reagent is solid catalyst 
consisting of a nickel alloy (about 85%) and Aluminium (to give porosity) in very fine grains 
and it is very used in many processes in industrial chemistry. 
 At a macroscopic level, Raney Nickel reagent looks like a fine grey powder stored and it 
is stored in aqueous solution because of its high propensity for self-expression when it is 
exposed  to atmospheric oxygen. However, microscopically, each granule represents a sort 
of sieve 3D with irregular shape and pores.  
Prior to reacting directly to the substrate, a number of washings must be performed with 
water and ethanol. These washings are very important to avoid mild racemization of the 
stereogenic center during the reaction. Probably this helps to eliminate any basic 
aluminated that might be responsible for this partial racemization.  
This reaction was performed under a nitrogen atmosphere at room temperature. Once 
all the reactants were added inside the balloon, a rubber balloon filled with hydrogen was 
attached as reservoir, the reaction was stirred for 48 hours and checked by TLC to see if it 
was completed. This reaction took place in two different balloons in which we obtained 
0.467 g (72% yield) and 0.569 g (88% yield). Below in scheme 22 the reduction reaction is 
shown.  
Scheme 22:  Reduction with Raney nickel 
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6.4.  OXIDATION OF THE ALCOHOL 
The next step, shown in scheme 23, involves the oxidation of the alcohol (16) to the 
aldehyde (9). The mechanism in this case is also regulated by the oxidant used in the first 
reaction named (i.e. TEMPO). However, in this case, we changed the stoichiometric oxidant for 
diacetate phenyl iodine and the reaction solvent is now dichloromethane.  
The reaction was ran at room temperature and quenched with sodium thiosulphite and it 
allows getting the aldehyde 9 in 99 % yield. The procedure was chosen because it avoided the 
racemization of the stereocenter in alpha of the aldehyde.  
Scheme 23: Oxidation of the alcohol 
6.5.  WITTIG REACTION 
 The Wittig reaction consists in reacting an aldehyde woith a triphenyl phosphonium ylide to 
give an alkene and triphenylphosphine oxide. The Wittig reaction is known experimentally as a 
[2+2] cycloaddition reaction, in which there is an attack by the nucleophilic carbon to the 
electrophilic carbon of the aldehyde group. The next elimination of the phosphine leads to the 
formation of the alkene.  
The reaction is conducted under an inert atmosphere at 0 ºC in dichloromethane and the 
reagents are taken with the double needle technique. The yield obtained was 58% and after the 
reaction was carried out, a 1H NMR test was performed in order to verify the formation of the 
desired product and then was isolated by doing a chromatography column.  
Scheme 24: Wittig’s reaction 
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6.6.  REDUCTION OF THE UNSATURATED ESTER (18) WITH RANEY NICKEL 
 
The resultant unsaturated ester (18) is reduced again with Nickel Raney reagent 
because in Palladium on Carbon (Pd/C) can occur catalyst poisoning. This fenomena 
involves partial or total deactivation of the catalyst brought about by its exposure to a range 
of chemical compounds such as amines, sulphides, thiols, lead and certain metal oxides. 
 Moreover, and unlike Pd/C, a catalytic amount of Raney nickel is enough to make the 
reaction. Also, one have to consider the importance of pre-washing the Raney nickel with 
water and ethanol under a hydrogen atmosphere and run the reaction overnight. When the 
conversion is completed, then it can be washed with EtOH and DCM to separate the 
product from the solid catalyst. The ester (19) yield was 77 % and is shown in the following 
scheme 25.  
Scheme 25: Reduction with Ni/Raney of the double bond in the ester 18 to give the intermediate 19 
 
6.7.  REDUCTION OF THE ESTER	(19) 
The last assessed reaction was the reduction of the ester (19) with LiAlH4. This reductant is 
used because ester and carboxylic acids are less reactive to nucleophiles than aldehydes or 
ketones. As a consequence, they can only be reduced using LiAlH4. The reaction normally 
ran in Et2O and followed by the Fieser method to work up the reaction, this process is 
explained in section 5.3.  
The reaction was conducted at 0ºC under an inert atmosphere. The yield of this last 
step was 99%. This alcohol (8) shown in the scheme 26 is our advanced precursor of 
interest.  
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Scheme 26:  Reduction with LiAlH4 
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7. EXPERIMENTAL SECTION 
7.1. MATERIALS AND METHODS 
Some reactions were conducted under a heat-dried or flame dried glassware under inert 
atmosphere of dry nitrogen with anhydrous solvents. Catalysis and reductions with sodium 
borohydride, were conducted to the air, all of the others have been conducted under anhydrous 
conditions and inert atmosphere. All solvents were anhydride which were supplied by Aldrich in 
Sureseal® bottles and used without purification. 
Analytical thin-layer chromatography (TLC) were carried out on Merck silica gel 60 F254 
plates and analysed by UV (254 nm) and stained with potassium permanganate (KMnO4) or 
cerium ammonium molybdate (CAM), with the specifically eluent needed in each case.  
Column chromatographies were performed under low-pressure (flash) conditions and 
performed on silica gel 240-400 mesh. 
1H NMR and 13C NMR spectra were obtained using the Varian Mercury 400 spectrometer 
MHz. Chemical shifts (δ) are reported in ppm as compared to tetramethylsilane standard (TMS), 
using solvent resonance as an internal standard (Deuterated chloroform: δ 7.27 ppm). Data is 
reported with the following order: Chemical shifts, multiplicity (s=singlet, d= doublet, t=triplet, 
q=quartet, m=multiplet, dd= doublet of doublets, ddd= doublet of doublet of doublets and their 
corresponding combinations). Coupling constants, J, were reported in Hertz. 
Specific rotations ([α]D) were determined at 25 ºC on a Perkin-Elmer 241 MC polarimeter. 
They were measured on CHCl3 and the wavelength used was the D line of sodium (589 nm).  
Enantiomeric exces was determined by high liquid chromatography performance with 
Agilent Technologies 1200 equipped with UV detector a variable wavelength (deuterium lamp: 
190-600 nm), using Daicel Chiralpak columns (0.46 cm x 25 cm) using as solvent for elution a 
mixture of isopropanol and n-hexane (15:85) with degree of purity for HPLC at 30ºC and a flow 
of 0.7 mL/min.  
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7.2. TOWARDS THE TOTAL SYNTHESIS OF BAULAMYCIN A. SYNTHON A 
7.2.1. Synthesis of methyl 3,5-dihydroxybenzoate (25) 
In a balloon 3,5-dihydroxybenzoic acid (5 g, 32.467 mmol) is mixed with MeOH (20 mL) and 
half a Pasteur of sulphuric acid. This reaction is left under heat in a reflux system for 72 h and 
the resultant solution is quenched using H2O and extracted with EtOAc (3x20 mL). The solvent 
is removed by vacuum and the resulting product is a beige solid (6.327 g, 99%). 
 
 
 
Beige solid. 1H NMR (CDCl3, 400 MHz): δ 7.20 (s,2H), 6.94 (d, J = 2.3 Hz, 2H), 
6.51 (t, J = 2.3 Hz, 1H), 3.83 (s, 3H). 13C NMR (CDCl3, 101 MHz): δ 165.9, 
159.8, 128.6, 109.6, 107.9, 51.5.  
 
 
7.2.2. Synthesis of methyl 3,5-bis((tert-butyldimethylsilyl)oxy)benzoate (26) 
The reaction is worked under nitrogen using a two-neck balloon. The ester (25) is first 
added (0.200 g, 1.19 mmol), imidazole (0.324 g, 4.76 mmol), DMF (2 mL) and TBSCl (0.833 g, 
5.528 mmol). The reaction is left for 48 h and quenched with H2O (10 mL). It is extracted with 
EtOAc (3x20 mL), the solvent is removed by vacuum and the desired ester (26) is isolated as 
colourless oil in quantitative yield pure by 1H NMR (0.472 g).  
 
 
Colourless oil. 1H NMR (CDCl3, 400 MHz): δ 7.10 (d, J = 2.2 Hz, 2H), 6.50 (t, J 
= 2.2 Hz, 1H), 3.88 (d, J = 9.1 Hz 3H), 0.96 n(s, 18H), 0.24 (s, 12H). 13C NMR 
(CDCl3, 101 MHz): δ 165.9, 157.2, 127.5, 116.7, 112.8, 30.3, 25.9, -4.43.  
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7.2.3. Synthesis of (3,5-bis ((tert-butyldimethylsilyl)oxy)phenyl)methanol (27) 
This reaction was carried under nitrogen, previously the system was worked under vacuum 
and heated to dry all the material. The ester (26) (7101.4 mg, 17.922 mmol, 1 equiv) is 
introduced inside a balloon with anhydrous THF (20 mL) after solid LiAlH4 (1630.3 mg, 35.84 
mmol, 2 equiv) was added. The reaction was stirred at 0 ºC for 72 h under nitrogen. To work up 
the reaction, first the mixture was diluted with diethyl ether at 0 ºC and it was added carefully 1.3 
mL of H2O, then 1.3 mL of 15% aqueous sodium hydroxide and again 3.9 mL of H2O. The 
reaction is warmed to room temperature and stirred for 15 min. Then MgSO4 anhydrous was 
added and stirred for 15 min and the reaction mixture was filtered to remove the salts. The 
solvent was eliminated at vacuum and the product obtained is a white solid. The compound is 
purified using a column chromatography, and it is obtained pure alcohol (27) (1 g, 45%).  
 
 
 
Colourless oil. 1H NMR (CDCl3, 400 MHz): δ 6.38 (s, 2H), 6.24 (s, 1H), 4.61 (s, 
2H), 0.98 (s, 18H), 0.21 (s, 12H). 13C NMR (CDCl3, 101 MHz): δ 156.7, 143.0, 
111.7, 111.1, 65.1, 25.6, - 4.43. 
7.2.4. Synthesis of 3,5-bis((tert-butyldimethylsilyl)oxy)benzaldehyde (28) 
The benzylic alcohol (27) is introduced in an open air balloon (100 mg, 0.27 mmol, 1 equiv) 
in DCM (3 mL) and MnO2 (0.141 g, 1.62 mmol, 4 equiv). The mixture was stirred at room 
temperature for 16 hours, washed with DCM (3x10 mL) and then filtered through celite. The 
filtrate was concentrated in vacuo to provide the product as a colourless oil, the product was 
purified by column chromatography and obtained 1g and 20% yield.  
 
 
 
Colourless oil. 1H NMR (CDCl3, 400 MHz): δ 9.84 (s, 1H), 6.94 (d, J = 2.2 Hz, 
2H), 6.54 (t, J = 2.3 Hz,1H), 4.61 (s, 2H), 0.98 (s, 18H), 0.21 (s, 12H). 13C NMR 
(CDCl3, 101 MHz): δ 191.8, 157.2, 138.3, 118.4, 114.3, 31.4, 25.6, -4.43. 
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7.3. TOWARDS THE TOTAL SYNTHESIS OF BAULAMYCIN A. SYNTHON B 
7.3.1 Synthesis of  4-phenylbutanal (10) 
To an ice-cold solution of alcohol (14) (1.35 g, 9 mmol, 1 equiv) in DCM (12 mL), a solution 
of KBr (0.147 g, 0.45 mmol, 0.1 equiv), Bu4NBr (0.107 g, 0.9 mmol, 0.05 equiv) in H2O (3 mL) 
and another solution of TEMPO (0.021 g, 0.1 mmol, 0.01 equiv ) in DCM (3.3 mL) were 
introduced also with a NaHCO3 saturated aq. solution (11.4 mL) inside the balloon. NaOCl (21 
mL) and a NaHCO3 aq. saturated solution (21 mL) were added dropwise over 30 min. The 
reaction mixture was stirred for 2 h, and quenched with a solution of Na2S2O3. The resultant 
mixture was extracted with Et2O (3 x 20 mL), washed with water and brine, dried over Na2SO4, 
and concentrated in vacuum. The crude product was purified by flash column chromatography 
(5% EtOAc in cyclohexane as eluent) to afford aldehyde (10) (1.246 g, 94%) as a yellowish oil. 
 
 
Yellowish oil. 1H NMR (CDCl3, 400 MHz): δ 9.64 (s, 1H), 7.58-6.82 (m, 5H), 
2.66 (t, J = 8.0 Hz, 2H), 2.53-2.36 (t, J = 6.0 Hz, 2H), 2.09-1.84 (m, 2H).  
7.3.2 Synthesis of (R)-2-(benzo[d][1,3]dithiol-2-yl)-4-phenylbutan-1-ol (15) 
To a solution of aldehyde (10) (222 mg, 1.5 mmol, 2 equiv) in 1,3-benzodithiolylium 
tetrafluoroborate (0.18 g, 0.75 mmol, 1 equiv) was added (R)-MacMillan catalyst imidazolidinone 
(0.038 g, 0.015 mmol, 0.02 equiv) in solution with CH3CN (2.9 mL) and H2O (2.9 mL). The 
mixture was stirred overnight at 0 ºC and extracted with Et2O (3x10 mL), washed with brine, 
dried over anhydrous Na2SO4, and concentrated in vacuum. The crude oil was worked-up by 
adding 4 mL of CH3OH and NaBH4 (0.250 g, 3 mmol, 2 equiv) at 0 ºC. After checking the 
reaction by TLC, H2O was added in order to quench the reaction. The crude reaction mixture 
was concentrated in vacuum again to remove the CH3OH and extracted with EtOAc (3x10 mL), 
after was purified by flash column chromatography (10% EtOAc in cyclohexane as eluent) to 
give the corresponding alcohol 15 (308.8 mg, 68%) as a yellow oil with an enantiomeric exces 
of 92%- 96%.  
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Yellowish oil. [α]D25 -21.2 (c 1.07, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 7.27-
7.14 (m, 7H), 7.02-6.97 (m, 2H), 5.20 (d, J = 6.1 Hz, 1H), 3.86 (dd, J1= 11.1 
Hz, J2= 4.2 Hz, 1H), 3.76 (dd, J1 = 11.1 Hz, J2 =4.2 Hz, 1H), 2.77-2.58 (m, 2H), 
1.97-1.88 (m, 2 H), 1.83-1.74 (m, 1H). 13C NMR (CDCl3, 101 MHz): δ 141.5, 
137.5, 128.3, 128.2, 125.9, 125.4, 122.0, 62.1, 47.0, 33.3, 29.7. 
 
 
7.3.2.1. Synthesis of methyl D-phenylalaninate (20) 
 
A 500 mL, two-necked, round-bottom flask, attached to an over-head stirrer, nitrogen inlet, 
reflux condenser bearing a drying tube, and a rubber septum, was purged with nitrogen and 
charged with D-phenylalanine (19) (2.404 g, 14.55 mmol, 1 equiv), followed by the addition of 
MeOH (10 mL). Thionyl chloride (2.6 g, 21.82 mmol, 1.5 equiv), was added cautiously by a 
dropping funnel over 25 min. to the rapidly stirring solution at 0 ºC. The nitrogen inlet was 
removed after the addition was complete and the nitrogen inlet was replaced with a rubber 
septum. The MeOH was removed under reduced pressure by rotary evaporation to provide 
the product (20) as a white solid (1.985 g, 76%). 
 
 
White solid. 1H NMR (CDCl3, 400 MHz): δ 7.35-7.32 (m, 5H), 3.75 (s, 3H), 
3.72 (dd, J1=7.9, J2=8.2 Hz, 1H), 3.09 (dd, J1= 13.5, J2= 5.2 Hz, 1H), 2.85 (dd, 
J1= 13.5, J2= 7.9 Hz,1H).  
 
 
7.3.2.2. Synthesis of (R)-2-amino-N-methyl-3-phenylpropanamide (21) 
In a schlenk flask, D-phenylalaninate (20) (1.985 g, 11.084 mmol) was added dropwise to a 
MeNH2/EtOH (33% m/m) (4.13 mL) solution. The resulting mixture was refluxed at 80 ºC in an 
oil bath under nitrogen and stirred overnight. The resulting residue was poured onto DCM (3 x 
10 mL) and the combined organic extracts were dried with Na2SO4 and concentrated to 
provide the amide (21) as a white solid (1.999 g, quantitative).  
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White solid. 1H NMR (CDCl3, 400 MHz): δ 7.32-7.20 (m, 5H), 4.16 - 4.12 (m, 
1H), 3.63 (dd, J = 9.1, 4.1 Hz, 1H), 3.27 (dd, J 1= 13.7, J2= 4.1 Hz, 1H), 2.79 
(d, J = 4.6 Hz, 3H), 2.69 (dd, J1= 13.7, J2 = 9.1, 1H). 
 
 
7.3.2.3. Synthesis of the (R)-MacMillan catalyst (23) 
In a two neck balloon under nitrogen, anhydrous MeOH (0.5 mL) was added to clean the 
balloon and then another 21.5 mL of MeOH were added for the reaction with a solution of amide 
(21) (1.999 g, 11.22 mmol, 1 equiv), purified acetone (4.08 mL, 55 mmol, 5 equiv) and pTSA 
(0.0193 g, 172 mmol, 0.01 equiv) at the reaction mixture was heated to reflux for 12 h. MeOH 
was removed in vacuum from the balloon and the resulting residue was precipitated with a 
solution of Et2O and HCl 1.0 M (15 mL) at 0ºC for overnight and then filtered through a gutch 
with one finger of silide in order to eliminate the possible residues. Then the liquid face is 
separated and it is evaporated to afford pure compound (23) (1.572 g, 55%). 
 
 
White solid. 1H NMR (CDCl3, 400 MHz): δ 7.29- 7.16 (m, 5H), 3.12 (dd, J1 = 
14.2, J2=6.8 Hz, 1H), 2.98 (dd, J1= 14.2, J2= 4.5 Hz, 1H), 2.68 (s, 3H), 1.19 (s, 
3H), 1.08 (s, 3H).  
 
7.3.3 Synthesis of (R)-2-methyl-4-phenylbutan-1-ol (16) 
A mixture of alcohol (15) (2.383 g, 7.89 mmol, 1 equiv) and Raney nickel (18 mL), which 
had been previously washed four times with 10 mL of water and three times with 10 mL of EtOH 
under hydrogen, were stirred and left 48 hours at room temperature. After the resulting mixture 
was washed with EtOH (6x10 mL) and DCM (6x10 mL) and AcOEt (5x10 mL) and then it was 
filtered through a silica gel pad with one finder of silica and then concentrated in vacuum to 
obtain the corresponding alcohol (16) (0.569 g, 88%), which was used in the following step 
without purification, we obtained 90% of enantiomeric excess.  
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Yellowish oil. 1H NMR (CDCl3, 400 MHz): δ 7.28-7.14 (m, 3H), 7.19-7.14 (m, 
2H), 4.21-3.95 (m, 1H), 3.53 (ddd, J1 = 28.2, J2 = 10.5 Hz, J3 = 6.0 Hz 1H), 
2.73-2.54 (m, 2H), 1.80-1.62 (m, 2H), 1.48-1.39 (m, 1H), 0.98 (d, J= 6.7 Hz, 
3H). 13C NMR (CDCl3, 101 MHz): δ 142.5, 129.1, 128.3, 128.2, 125.8, 125.6, 
67.9, 35.2, 34.8, 33.2, 17.0. 
 
7.3.4 Synthesis of (R)-2-methyl-4-phenylbutanal (17) 
 
To a water bath solution of alcohol (16) (937 mg, 5.7 mmol, 1 equiv) in DCM (5.7 mL) was 
added TEMPO (89.1 mg, 0.57 mmol, 0.1 equiv) and PhI(OAc)2 (2207 mg, 6.8 mmol, 1.2 
equiv). The reaction mixture was stirred for 2 h at room temperature and subsequently 
quenched with Na2S2O3 (5 mL). The resultant mixture was extracted with DCM (3x10 mL) and 
washed with brine (20 mL), dried over Na2SO4 and filtered. The solvent is removed in vacuum 
to obtain aldehyde (17) (0.926 g, 99%) that is used in the following step without purification.   
 
 
 
Yellowish oil. 1H NMR (CDCl3, 400 MHz): δ 6.97-6.94 (m, 5H), 1.99 (d, J= 4.9, 
1H), 1.95 (dt, J1 = 4.9, J2 = 2.5 Hz, 2H), 1.32 (t, J = 7.1 Hz, 2H), 1.18 (dt, J1 = 
14.7, J2 = 7.1 Hz, 3H). 13C NMR (CDCl3, 101 MHz): δ 204.1, 142.6, 128.5, 
128.1, 125.9, 46.0, 34.2, 30.1, 14.0.  
 
7.3.5 Synthesis of ethyl (R,E)-4-methyl-6-phenylhex-2-enoate (18) 
 
To a solution of the unpurified aldehyde (17) (98 mg, 0.609 mmol, 1 equiv) in anhydrous 
DCM (1 mL) is added the Wittig reagent (ethoxycarbonylmethylene)triphenylphosphorane 
(233 mg, 0.669 mmol, 1.1 equiv) under nitrogen and the resulting mixture is stirred at 0ºC 
overnight.  
The solvent was removed in vacuum, AcOEt and 2 spoons of silica were added inside the 
balloon in order to prepare the solid for the column chromatography. The crude was purified 
by flash column chromatography on silica gel first with 100% cyclohexane and after removing 
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the PPh3, the polarity was increased to 95:5 (Cyclohexane/Et2O) and the ester unsaturated 
(18) is obtained (81 mg, 62%).  
 
 
Yellowish oil. [α]D25 –24.4 (c 1.0, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 
7.71-7.62 (m, 2H), 7.57-7.42 (m, 3H), 6.90 (dd, J1= 15.7, J2= 8.0 Hz, 
1H), 5.80 (d, J = 15.7, 1H), 4.18 (q, J = 7.1 Hz, 2H), 2.64-2.54 (m, 2H), 
2.37-2.29 (m, 1H), 1.73-1.64 (m, 2H), 1.25 (t, J = 7.1 Hz, 3H), 1.08 (d, J 
= 6.7 Hz, 3H).13C NMR (CDCl3, 101 MHz): δ 166.6, 154.0, 141.9, 128.3, 
125.8, 60.2, 37.6, 36.0, 33.4, 19.4, 14.3. 
 
7.3.5 Synthesis of ethyl (R)-4-methyl-6-phenylhexanoate (19) 
A mixture of α,β-unsaturated ester (18) (697.2 mg, 3.19 mmol, 1 equiv) and Raney nickel (2 
mL), which had been previously washed with EtOH (3x10 mL) and DCM (3x10 mL) under 
hydrogen, were stirred 12 hours at room temperature. After the resulting mixture was washed 
with EtOH (6x10 mL) and DCM (6x10 mL). These solvents were concentrated under reduced 
pressure. The suspension was filtered through a silica pad and washed with AcOEt (5x10 mL) 
and then concentrated in vacuum to obtain the desired ester (16) (545 mg, 77%), which was 
used in the following step without purification. 
 
 
Yellowish oil. [α]D25 +3.04 (c 1.1, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 
4.10 (q, J = 7.1 Hz, 2H), 2.68-2.52 (m, 2H), 2.38-2.20 (m, 2H), 1.75-1.58 
(m,2H), 1.54-1.39 (m, 1H), 1.53-1.39 (m, 2H), 1.25-1.22 (m, 3H), 0.93 (d, 
J = 6.0 Hz, 3H). 13C NMR (CDCl3, 101 MHz): δ 173.9, 142.6, 129.1, 
128.3, 128.2, 125.6, 60.2, 38.6, 33.3, 32.1, 32.0, 31.8, 19.2, 14.2. 
7.3.7 Synthesis of (R)-3-methyl-5-phenylpentan-1-ol (8) 
A 50 mL, three-necked, round-bottom flask, equipped with a magnetic stir-bar, was purged 
with nitrogen and charged with ester (19) (545 mg, 2.32 mmol, 1 equiv) followed by anhydrous 
Et2O (8 mL). The solution was then cooled to 0 ºC using an ice bath. Lithium aluminium hydride 
in THF (1M, 2.78 mL, 2.78 mmol, 1.2 equiv) was added cautiously by a dropping funnel over 10 
min. After the addition was complete the resulting solution was stirred at room temperature for 3 
h, whereupon the solution was once again cooled to 0 ºC and H2O (0.1 mL), 15% NaOH ( 0.10 
mL), H2O (0.3 mL) were added sequentially. Upon warming the reaction mixture to room 
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temperature, anhydrous MgSO4 (200 mg) were added and the resulting white suspension was 
filtered through Celite (5 g) and the Celite pad was washed with Et2O (40 mL). The filtrate was 
concentrated under reduced pressure by rotary evaporation to afford a yellow oil (443 mg, 99%) 
of alcohol (8).  
 
 
Yellowish oil. [α]D25 +6.42 (c 1.4, CHCl3). 1H NMR (CDCl3, 400 MHz): δ 7.29-
7.23 (m, 2H), 7.20-7.12 (m, 3H), 3.61 (t, J = 6.7, 2H), 2.70-2.52 (m, 2H), 
1.70-1.51 (m, 3H), 1.50-1.36 (m,  3H), 1.26-1.14 (m, 1H), 0.94 (m, J = 6.3 
Hz, 3H).  13C NMR (CDCl3, 101 MHz): δ 142.9, 128.3, 128.2, 123.8, 63.1, 
38.8, 36.3, 33.4, 32.8, 32.3, 21.0. 
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8. CONCLUSIONS 
The study of the Baulamycin A has shown that in the synthesis of the synthon A compounds 
25 and 26 were obtained in excellent yields. However, the yields obtained from compounds 27 
and 28 did not meet the foreseen expectations. Therefore, further studies regarding the 
oxidation of the alcohol using MnO2 must be reviewed.  
Synthon B compounds 10, 16, 17, 19 and 8 have also been obtained in high yields. The 
organocatalysis using (R)- MacMillan imidazolidinone allowed for achieving the product 15 
needed in order to be able to proceed with the synthesis. The enantiomeric excess was also 
high giving 92-96% of pure optical compound 15.  
The synthesis of (R)- MacMillan catalyst has afforded product 23 in an overall yield of 55%, 
this yield is not what should be expected because probably the solution of Et2O in HCl 1.0M did 
not make the precipitation of the compound completed.  
In conclusion, 4 steps were required to synthesize the synthon A and 6 steps for the 
synthon B.  
We succeeded in our attempt to get the aimed intermediates and, from now on, further 
reactions of the addition of the stereocenters in synthon B and formation of other groups in 
synthon A have to be performed.   
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10. ACRONYMS 
 
MRSA                                          Methicillin-resistant Staphylococcus aureus  
AsbA                                            Anthracis siderophore biosynthesis protein A 
SbnE Synthetase E of Staphyloferrin B  
NMR                                             Nuclear magnetic resonance 
PG              Protecting group 
r.t. Room temperature 
TBDMSCl                                     tert-butyldimethylsilyl chloride 
THF                                              Tetrahydrofuran 
TLC                                             Thin-Layer Chromatography 
EtOH                                            Ethanol 
MeOH                                          Methanol 
DMF                                             Dimethylformamide 
UV                                                Ultraviolet 
EtOAc                                          Ethyl Acetate 
PTSA                                            p-Toluenesulfonic acid 
TEMPO (2,2,6,6-tetramethylpiperidin-1-yl)oxyl 
DCM Dicloromethane 
SN2 Bimolecular nucleophilic substitution 
Et2O Diethyl ether 
Ni/Raney Raney Nickel  
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H2 Hidrogen 
N2 Nitrogen 
Pd/C Palladium on carbon 
HPLC High performance liquid chromatography 
CDCl3 Deuterated chloroform 
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APPENDIX : COMPOUND NUMERATION 
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